Matches in Wikidata for { <http://www.wikidata.org/entity/Q79634770> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q79634770 description "article scientifique publié en 2007" @default.
- Q79634770 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q79634770 description "scientific article published on 24 January 2007" @default.
- Q79634770 description "wetenschappelijk artikel" @default.
- Q79634770 description "наукова стаття, опублікована в січні 2007" @default.
- Q79634770 name "Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen" @default.
- Q79634770 name "Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen" @default.
- Q79634770 type Item @default.
- Q79634770 label "Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen" @default.
- Q79634770 label "Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen" @default.
- Q79634770 prefLabel "Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen" @default.
- Q79634770 prefLabel "Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen" @default.
- Q79634770 P1433 Q79634770-FFC5A2BC-A454-4CE0-9DFD-4CE6EB8D87FB @default.
- Q79634770 P1476 Q79634770-1A1C268B-0D38-4ED4-8930-BBC447AC9C6F @default.
- Q79634770 P2093 Q79634770-482F4CF5-CDA7-45AB-B930-EA9657AD95B1 @default.
- Q79634770 P2093 Q79634770-65671B73-315E-44C1-B299-143F6814C7D3 @default.
- Q79634770 P2093 Q79634770-7CD21CC8-C489-4BB4-B78D-EA1FF22B3159 @default.
- Q79634770 P2093 Q79634770-87BD811E-DD34-410F-96CB-2EC2511C4999 @default.
- Q79634770 P2093 Q79634770-C03A1EDA-7AE2-4197-A9BE-7CDD2D608779 @default.
- Q79634770 P2093 Q79634770-DBD95029-97C5-442E-9D43-EF2B77FC1CB3 @default.
- Q79634770 P2093 Q79634770-FF39B4CB-8B66-4A18-ADFA-6E8F94D3F80C @default.
- Q79634770 P2888 Q79634770-18D2F926-6976-4EA8-ACE4-7FE558C80C93 @default.
- Q79634770 P304 Q79634770-AE17CAEE-4F63-4D72-A7CB-F2544212D3C3 @default.
- Q79634770 P31 Q79634770-46C3CB50-8E3A-42CD-9C28-FCF59DD15DA3 @default.
- Q79634770 P356 Q79634770-ACB63A1B-3D26-4E13-BC2F-0B48D82C2E62 @default.
- Q79634770 P433 Q79634770-32B3269E-0185-4843-B674-AB0BD5BB7630 @default.
- Q79634770 P478 Q79634770-27717D68-6836-4904-B989-FE70A2AF407B @default.
- Q79634770 P577 Q79634770-E9449073-9D79-4F79-9E84-63D3C2E43CE2 @default.
- Q79634770 P6179 Q79634770-895C171B-D810-423B-B84D-1723A5187879 @default.
- Q79634770 P698 Q79634770-81FC9657-31E0-465B-B59E-339648EEDD75 @default.
- Q79634770 P921 Q79634770-21E3D5AA-C221-4FBF-96C2-9E4774CB3BC7 @default.
- Q79634770 P921 Q79634770-E4936B34-AE0C-4F45-92DC-6BC47FB98CE0 @default.
- Q79634770 P356 S10549-006-9483-6 @default.
- Q79634770 P698 17245540 @default.
- Q79634770 P1433 Q326085 @default.
- Q79634770 P1476 "Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial" @default.
- Q79634770 P2093 "ATAC Trialists' Group" @default.
- Q79634770 P2093 "David Cella" @default.
- Q79634770 P2093 "Deborah Dobrez" @default.
- Q79634770 P2093 "Gershon Y Locker" @default.
- Q79634770 P2093 "Robert Mansel" @default.
- Q79634770 P2093 "Sanjay K Gandhi" @default.
- Q79634770 P2093 "Sonja Sorensen" @default.
- Q79634770 P2888 s10549-006-9483-6 @default.
- Q79634770 P304 "229-238" @default.
- Q79634770 P31 Q13442814 @default.
- Q79634770 P356 "10.1007/S10549-006-9483-6" @default.
- Q79634770 P433 "2" @default.
- Q79634770 P478 "106" @default.
- Q79634770 P577 "2007-01-24T00:00:00Z" @default.
- Q79634770 P6179 "1049361234" @default.
- Q79634770 P698 "17245540" @default.
- Q79634770 P921 Q412178 @default.
- Q79634770 P921 Q419143 @default.